Skip to search formSkip to main contentSkip to account menu

K1K2Pu

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Plasminogen ActivatorRecombinant Fusion Proteins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1998
Review
1998
Newer thrombolytic drugs for acute myocardial infarction.
Arterial thrombosis is the underlying cause of a wide variety of cardiovascular diseases such as myocardial infarction, stroke… 
1995
1995
Antithrombotic effects of thrombolytic agents in a platelet-rich femoral vein thrombosis model in the hamster.
BACKGROUND The extent and mechanism of the antithrombotic properties of fibrin-selective and non-fibrin-selective thrombolytic… 
Review
1993
Review
1993
Thrombolysis in acute lower limb ischaemia.
1993
1993
Coronary thrombolysis with K1K2PU, a chimeric tissue‐type and urokinase‐type plasminogen activator: A feasibility study in six patients with acute myocardial infarction
Background:K1K2PU is a recombinant chimeric tissue-type and urokinase-type plasminogen activator consisting of the two kringle… 
1992
1992
Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)